The last 12 months have been more than a little eventful for Epsilon Imaging.
The Ann Arbor-based start-up launched its principal product called
Stress Echo, an ultrasound for cardiac imaging that quantitatively measures the strength and weakness of the heart's muscles. It now has 12 installations of this technology in hospitals across the country and is looking to ramp up that number even more.
Epsilon Imaging is also gearing up to launch its second product later this month, a
cardio oncology application. The technology allows doctors to see if cancer medications are negatively impacting the heart early in the process.
"The people who undergo treatment, some will have their heart come under attack from the medication," says
Eric Sieczka, president of
Epsilon Imaging. "The problem is you won't notice that until 8-9 months later."
The firm has hired two people over the last year, expanding its staff to 12. Its two recent hires include a director of sales and a software developer. Sieczka also expects to begin fundraising for a Series B round of seed capital worth approximately $5 million, which would double its Series A funding from a few years ago.
"This has been a pretty exciting year for us," Sieczka says.
Source: Eric Sieczka, president of Epsilon Imaging
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.